BridgeBio Pharma Inc

10-Year Study

BBIO.US · Healthcare · US · Common Stock

Executive Summary: BridgeBio Pharma Inc has compounded at 16.7% annually over the last 10 years, with a maximum drawdown of 90.4% and an annualized volatility of 130.9%.

1Y CAGR
+143.6%
3Y CAGR
+81.0%
5Y CAGR
+5.6%
10Y CAGR
+16.7%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
90.4%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.61
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
1.17
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
74.0%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2023 · +429.8%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2021 · -76.5%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
57%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
20261.0-14.011.74.4————————1.3%
202524.72.0-0.911.0-10.726.19.59.50.320.615.06.2178.8%
2024-15.1-0.4-9.5-17.19.3-9.62.47.3-8.6-8.115.71.3-32.0%
202321.823.145.2-12.4-5.525.4103.5-14.6-11.8-1.310.340.6429.8%
2022-40.8-21.030.1-21.0-14.832.9-4.621.2-5.34.9-10.2-18.7-54.3%
2021-20.224.5-12.8-9.25.93.0-12.3-6.2-6.55.4-18.0-58.8-76.5%
2020-1.6-7.6-9.05.3-3.911.2-13.76.125.72.330.941.5102.9%
2019——————8.83.9-29.65.328.320.930.0%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 130.9%. The dominant macroeconomic risk driver is SHV.US, accounting for 68.2% of variance. Idiosyncratic stock-specific factors contribute 19.2%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2019-06-0110000
2019-07-0110882.461994809048
2019-08-0111301.446051167964
2019-09-017960.697070819429
2019-10-018383.388950685947
2019-11-0110752.688172043012
2019-12-0112995.921394141638
2020-01-0112788.283277715982
2020-02-0111820.541342232109
2020-03-0110752.688172043012
2020-04-0111319.98516870597
2020-05-0110875.046347793845
2020-06-0112091.212458286986
2020-07-0110433.81535038932
2020-08-0111071.560993696701
2020-09-0113911.753800519098
2020-10-0114230.626622172786
2020-11-0118628.105302187618
2020-12-0126366.332962550983
2021-01-0121045.606229143494
2021-02-0126206.89655172414
2021-03-0122840.192806822393
2021-04-0120734.149054505007
2021-05-0121950.31516499815
2021-06-0122602.89210233593
2021-07-0119818.31664812755
2021-08-0118579.903596588803
2021-09-0117378.56878012607
2021-10-0118309.232480533927
2021-11-0115016.685205784206
2021-12-016184.649610678532
2022-01-013659.6218020022247
2022-02-012892.10233592881
2022-03-013763.4408602150543
2022-04-012973.6744530960323
2022-05-012532.4434556915094
2022-06-013366.703744901743
2022-07-013210.975157582499
2022-08-013893.2146829810904
2022-09-013685.576566555432
2022-10-013867.259918427883
2022-11-013474.230626622173
2022-12-012825.361512791991
2023-01-013440.860215053763
2023-02-014234.334445680385
2023-03-016147.571375602521
2023-04-015383.759733036707
2023-05-015087.133852428625
2023-06-016377.456433073786
2023-07-0112981.090100111234
2023-08-0111090.100111234706
2023-09-019777.530589543938
2023-10-019655.172413793103
2023-11-0110645.161290322581
2023-12-0114968.48350018539
2024-01-0112714.126807563958
2024-02-0112662.217278457547
2024-03-0111464.590285502412
2024-04-019499.44382647386
2024-05-0110385.61364479051
2024-06-019391.91694475343
2024-07-019621.802002224695
2024-08-0110326.288468668892
2024-09-019440.118650352244
2024-10-018680.014831294031
2024-11-0110044.493882091212
2024-12-0110174.26770485725
2025-01-0112684.464219503154
2025-02-0112940.304041527625
2025-03-0112817.94586577679
2025-04-0114223.210975157583
2025-05-0112699.295513533558
2025-06-0116010.381905821283
2025-07-0117526.88172043011
2025-08-0119191.694475342974
2025-09-0119258.43529847979
2025-10-0123225.806451612905
2025-11-0126700.037078235076
2025-12-0128361.14200964034
2026-01-0128650.352243233225
2026-02-0124649.610678531702
2026-03-0127534.297367445313
2026-04-0128739.34000741565
Annual Return Matrix
YearAnnual Return
20201.028815977175464
2021-0.7654338349036703
2022-0.5431654676258992
20234.297900262467191
2024-0.3202873420857071
20251.7875364431486878
20260.01333507648058574
Total Factor Risk
1.308626254211193
VTI.US Exposure
0.05158335301160389
VEA.US Exposure
-0.005930207731126886
VWO.US Exposure
-0.0069117439978504495
QQQ.US Exposure
-0.0023692211740259056
VTV.US Exposure
0.007455357230657521
IJR.US Exposure
0.01692182510379916
QUAL.US Exposure
0.03316175512014645
SHV.US Exposure
0.6822526660094922
TLT.US Exposure
-0.004394226936885427
LQD.US Exposure
0.015952622995099836
HYG.US Exposure
-0.00015358570191964735
GLD.US Exposure
0.0025950027504220616
USO.US Exposure
-0.0009251966487639888
VNQ.US Exposure
0.017937624933805785
BTC-USD.CC Exposure
-0.004145016757569923
CPER.US Exposure
0.002016439114534207
VIX.INDX Exposure
0.0012647221720002268
UUP.US Exposure
0.0037030084346982802
TIP.US Exposure
-0.002004127217813987
Idiosyncratic Exposure
0.1919889492896967
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
130.9%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$14.2B
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+9.1%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+23.3%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
3.0% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
1.09
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is BridgeBio Pharma Inc a high-risk investment?

BridgeBio Pharma Inc (BBIO.US) has an annualized volatility of 130.9% and experienced a maximum drawdown of 90.4% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of BBIO.US?

Over the past 10 years, BBIO.US has generated a Compound Annual Growth Rate (CAGR) of 16.7%. It has had a positive return in 57% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on BridgeBio Pharma Inc

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest